AcelRx Pharmaceuticals, Inc.
Simplifying Acute Pain Relief
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. In November of 2018, its lead product candidate DSUVIA® (sufentanil sublingual tablet 30 mcg) was approved by the U.S. Food and Drug Administration.